Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 101 of 110 Updated Nov 17, 2026

Thymagen

Khavinson thymus bioregulator

RUSSIAN RESEARCH · KHAVINSON SHORT PEPTIDE BIOREGULATOR

▓ 1 indexed citations across PubMed (1).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

1 citation across 1 tier

Tap any tier to jump to that section of the bibliography.

Mechanism of action

Thymic gene expression modulation

Researched effects

Thymic function; T-cell modulation; immunosenescence

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

Oral capsule 1-2x daily

Known concerns

Limited Western evidence

Top-ranked picks

1 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. [Effect of thymagen, thymalin and vilosen on the cAMP and cGMP levels and phosphodiesterase activity in spleen lymphocytes during sensitization and anaphylactic shock].

    Ukrainskii biokhimicheskii zhurnal (1978) · 1991 — RESEARCH ARTICLES · AUTHORITY 32.0

Full citation library

Year distribution

Research Articles

1
  1. 1.

    Demidov SV, Kostromin AN, Kuĭbeda VV, Chernaia IV, et al. · Ukrainskii biokhimicheskii zhurnal (1978) · 1991 · PMID 1659006

    It is established that the effect of thymus-derived species is connected with the cyclic nucleotide system. The action of thymus-derived immunocorrectors (thymalin, thymagen, vilosen) on catabolic processes of cyclic nucleotides has been observed under conditions of anaphylaxy and sensibilization. They show that sensibilization of the animal is bound up with a decrease of the cAMP/cGMP ratio. Anaphylaxis induces levelling of the cAMP/cGMP ratio up to the reference level. So, activity of enzymes…

Curated sources on file

3
  1. 1.
  2. 2.
  3. 3.
    Note: Primary literature on this peptide is published largely in Russian gerontology journals (Adv Gerontol, Bull Eksp Biol Med). English-indexed sources are limited to comprehensive Khavinson-laboratory reviews; entry confidence is correspondingly lower.

Continue reading